Den Rozhnovsky / Shutterstock.com

18 February 2025NewsAmericasMarisa Woutersen

Apple voids Omni MedSci wearable tech patent

Patent Trial and Appeal Board rules all challenged claims were unpatentable | Decision follows Federal Circuit review that revived Apple’s challenge.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More features

Fed Circ: Generic doesn’t infringe Metacel MS drug

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025

Strategic IP protection for biotech-related GenAI

South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug

In vivo cell therapy: A world beyond ex vivo engineering

Patent litigator with biotech and medical device background joins Sterlington

Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency